News
The pharma industry’s reputation dropped slightly again among patient groups, largely due to drug pricing issues.
Johnson & Johnson MedTech, Stryker and Zimmer Biomet lead MassDevice's annual list of the world's largest orthopedic device ...
Obesity drugmaker Novo Nordisk's CFO said on Wednesday he was sceptical that U.S. President Donald Trump's executive order to ...
However, integrating all services into one platform like retail or telehealth companies do is not something drugmakers are likely to achieve anytime soon — particularly due to regulatory challenges.
New analysis from GlobalData has revealed the top 20 pharma companies by revenue ... On the profitability side, 10 out of the top 20 companies reported over 25% growth in net profit.
Paysign's patient affordability segment is experiencing rapid growth with higher margins, and is expected to double revenue ...
Academics and pharma executives ... biotech projects or companies fail. Only a tiny few biotech innovations will become globally impactful successes. Further, it can take 10-20 years for ...
Bain Capital is in talks to buy contract drug manufacturer PCI Pharma Services at a valuation of $10 billion, Bloomberg News reported on Friday, citing people familiar with the matter.
In fact, based on 2024 data, nine of the top 10 pharma companies by revenue have ecodesign targets and activities embedded into their sustainability strategies, Krista observes. “The breadth of these ...
Aurobindo Pharma and Gland Pharma have fallen 6-10 per cent each in the past one week and 20-23 per cent in 2025 so far. Glenmark Pharma is down 10 per cent for the week month period and 14.45 per ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results